Washington, DC (PRWEB) November 18, 2013
The award winning MDLinx content, http://www.mdlinx.com, is now offered as membership benefit to all PDR’s members. Through this tightly integrated partnership with PDR, http://www.pdrnetwork.com, M3 is now capable of reaching nearly 600,000 US physicians on behalf of its customers in brand marketing, market research, and physician recruiting.
“PDR is a one-of-a-kind brand, trusted by physicians to deliver highly relevant drug information,” remarked Aki Tomaru, CEO of M3 USA. “MDLinx has been the leading website for U.S. specialty physicians. With the launching of PDR Powered by MDLinx, http://www.mdlinx.pdr.net, M3 adds 330,000 US physicians, significantly extending our reach in key specialties such as primary care, psychiatry, urology and pediatrics. Combined with our existing industry leading coverage in oncology, rheumatology and endocrinology, our HCP reach may be the best to the specialties that matter most to both Pharmaceutical and Life Science companies. This represents a tremendous opportunity for our customers.”
“We are thrilled to partner with MDLinx, as PDR continues to expand our HCP offerings,” comments Rich Altus, President of PDR. “Their practical medical information can now be found right on our site, PDR Powered by MDLinx. This powerful offering will provide even more reasons for prescribers to rely on PDR for the most relevant drug and clinical information inside and outside of workflow.” PDR continues to lead the industry by providing drug information and patient support inside the physician’s Electronic Health Record (EHR).
MDLinx is the most actively used website among HCPs today. Now with the PDR partnership in place, M3 offers the greatest reach in the industry to its customers. This is M3 Group’s second industry leading partnership inked in just over two months, the last being an integration with MMIT, to deliver market access information directly to Healthcare Providers.
“We are committed to helping HCPs get the latest medical information available to help them make the most informed prescribing decisions for their patients,” remarks Tomaru. “The PDR partnership is the next great step in our continued growth strategy in the United States.”
About M3 Group
The M3 Group operates in the US, Asia, and Europe with over 1.5 million physician members globally via its physician websites such as http://www.m3.com, http://www.mdlinx.com, http://www.doctors.net.uk, and http://www.medigate.net.. M3 Inc. is a publicly traded company on the Tokyo Stock Exchange (jp:2413) with subsidiaries in major markets including USA, UK, Japan, S. Korea, and China. M3 Group provides services to healthcare and the life science industry. In addition to market research, these services include medical education, ethical drug promotion, clinical development, job recruitment, and clinic appointment services. M3 has offices in Tokyo, Washington D.C., Fort Washington, PA, Oxford, London, and Seoul.
View M3 Group
About PDR Network
PDR Network is the nation’s leading aggregator and distributor of FDA-approved drug safety information and patient support services, reaching healthcare providers directly through the Physicians’ Desk Reference® suite of digital and print services. PDR® Communications provides direct access to more than one million healthcare professionals with both promotional and clinical vehicles. Healthcare professionals access trusted PDR content across channels, including via the Physicians’ Desk Reference (PDR), the most recognized drug information reference available in the U.S., now available in multiple formats; PDR interactive drug services for Electronic Health Record (EHR) systems; PDR.net®, the online home of the PDR; and mobilePDR® for handheld devices. The PDR Pharmacy Discount Card helps patients afford their medications – is a free service to physicians and their patients. For more information on our products and services, please visit http://www.pdrnetwork.com.
View PDR Network